Aimed Alliance has released new recommendations for reforming the federal 340B Drug Pricing Program and advancing state-based alternatives to strengthen…
On August 14, Aimed Alliance submitted a comment to the Senate Finance Committee’s Request for Information on Commonsense Policy Options…
A new Yale University study raises questions about how the Trump Administration’s proposed Medicare international reference pricing (IRP) models, GLOBE…
On August 27, 2026, Aimed Alliance submitted feedback on Senator Cassidy’s 340B Drug Pricing Integrity and Affordability for Patients Act…
Aimed Alliance released three new patient-centered resources as part of its Patients & PDABs: Ensuring a Voice in the Process…
On July 30, the Senate Health, Education, Labor, and Pensions (HELP) Committee unanimously approved the Health Information Privacy Reform Act…
After reviewing state Medicaid formularies and utilization management policies, Aimed Alliance recently sent letters to five state Medicaid programs urging…
On August 7, 2026, Aimed Alliance sent the West Virginia House of Delegate a letter supporting H.B. 4984, which would…
On August 13, 2026, Aimed Alliance submitted comments to CMS regarding its proposed rule to codify the Medicare Drug Price…
In a 2026 JAMA article, researchers proposed a federal licensure framework for autonomous clinical artificial intelligence (AI) systems. The framework…